Publications by authors named "Brenda Kitchen"

Claim this Profile
I
Index of suspicion.
Senthilkumar Sankararaman, Kamakshya Patra, Wanda Wells, Tania Sarker, Brenda Kitchen

Pediatr Rev· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A report of renal artery embolization for hematuria facilitating neoadjuvant chemotherapy in an unresectable malignant renal rhabdoid tumor.
Ruchika Sharma, Brenda J Kitchen, Rajen Mody, Aghiad Chamdin, Steven Bruch

Pediatr Surg Int· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group.
Judith G Villablanca, Wendy B London, Arlene Naranjo, Patrick McGrady, Matthew M Ames, Brenda J Kitchen

Clin Cancer Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease.
Rebecca A Marsh, Lisa Madden, Brenda J Kitchen, Rajen Mody, Brad McClimon

Blood· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency.
Rebecca A Marsh, Joyce Villanueva, Kejian Zhang, Andrew L Snow, Helen C Su, Brenda Kitchen

Cytometry B Clin Cytom· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large granular lymphocyte leukemia (LGL) in a child with hyper IgM syndrome and autoimmune hemolytic anemia.
Brenda J Kitchen, Laurence A Boxer

Pediatr Blood Cancer· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015).
Susan M Blaney, Mark Bernstein, Kathleen Neville, Jill Ginsberg, Brenda Kitchen

J Clin Oncol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis